Theratechnologies to Announce Financial Results for the Second Quarter of 2015
Marketwired - Fri Jun 26, 11:18AM CDT
Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the second quarter ended May 31, 2015, on Tuesday, July 14, 2015, before markets open.
TH.TO: 1.84 (+0.15)
Lipodystrophy Therapeutics Pipeline Review, H1 2015 - 6 Companies & 6 Drug Profiles
M2 - Tue Jun 09, 6:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hd9j66/lipodystrophy) has announced the addition of the "Lipodystrophy - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Lipodystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lipodystrophy and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Aileron Therapeutics, Inc. - Ambrx, Inc. - AstraZeneca PLC - Bolder Biotechnology, Inc. - Theratechnologies Inc. - Zydus Cadila Healthcare Limited Drug Profiles - ALRN-5281 - ARX-328 - BBT-031 - metreleptin - saroglitazar - tesamorelin acetate For more information visit http://www.researchandmarkets.com/research/hd...odystrophy
AMBX: (), AZN: 66.45 (+1.90)
Announcements in Conjunction With Theratechnologies Annual Meeting
Marketwired - Wed May 20, 10:43AM CDT
Theratechnologies Inc. (TSX: TH) today held its annual meeting of shareholders, chaired by Dawn Svoronos, chair of the board of Theratechnologies.
TH.TO: 1.84 (+0.15)
Authorization to Discontinue Class Action Proceedings Against Theratechnologies Granted
Marketwired - Fri May 15, 10:00AM CDT
Theratechnologies Inc. (TSX: TH) today announced that the Superior Court of Quebec has authorized 121851 Canada Inc. to discontinue all class action proceedings filed pursuant to the Securities Act (Quebec) and the Civil Code of Quebec against the Company, a director and a former president and chief executive officer.
TH.TO: 1.84 (+0.15)
Cognitive Impairment - Pipeline Review, H1 2015
M2 - Thu May 14, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z64d6n/cognitive) has announced the addition of the "Cognitive Impairment - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Cognitive Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cognitive Impairment and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AbbVie Inc. - AstraZeneca PLC - Avineuro Pharmaceuticals, Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Dart NeuroScience LLC - Eisai Co., Ltd. - Eli Lilly and Company - Evotec AG - F. Hoffmann-La Roche Ltd. - FORUM Pharmaceuticals Inc. - H. Lundbeck A/S - Iproteos S.L. - Merck & Co., Inc. - Mithridion, Inc. - Mnemosyne Pharmaceuticals, Inc. - Neuralstem, Inc. - Novartis AG - Panacea Pharmaceuticals, Inc. - Pfizer Inc. - Pherin Pharmaceuticals, Inc. - Sanofi - Shire Plc - Suven Life Sciences Ltd. - Takeda Pharmaceutical Company Limited - Teva Pharmaceutical Industries Limited - Theratechnologies Inc. - Upsher-Smith Laboratories, Inc. - Vicore Pharma AB - Virogenomics, Inc. For more information visit http://www.researchandmarkets.com/research/z64d6n/cognitive
PFE: 34.36 (+0.50), LLY: 88.29 (+0.81), BMY: 69.27 (+1.38), AZN: 66.45 (+1.90), MRK: 57.95 (+0.57), SHPG: 250.34 (+7.35), TEVA: 61.38 (-0.75), ABBV: 69.23 (+1.26), CUR: 1.69 (-0.01), NVS: 103.22 (+3.20)
Supreme Court of Canada Rules in Favour of Theratechnologies
Marketwired - Fri Apr 17, 9:09AM CDT
Theratechnologies Inc. (TSX: TH) announced today that the Supreme Court of Canada has granted its appeal and dismissed 121851 Canada Inc.'s motion for leave to commence an action based on the secondary market liability provisions of the Securities Act (Quebec) against Theratechnologies, one of its directors and a former president and chief executive officer.
TH.TO: 1.84 (+0.15)
Theratechnologies Announces Financial Results for First Quarter of 2015
Marketwired - Tue Apr 14, 6:01AM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the first quarter ended February 28, 2015.
TH.TO: 1.84 (+0.15)
Theratechnologies to Announce Financial Results for the First Quarter of 2015
Marketwired - Tue Apr 07, 11:43AM CDT
Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the first quarter ended February 28, 2015, on Tuesday, April 14, 2015, before markets open.
TH.TO: 1.84 (+0.15)
IIROC Trade Resumption - Theratechnologies Inc.
Newsfile Corp - Tue Mar 31, 7:00AM CDT
Trading resumes in:
Health Canada Approves 1mg/vial Presentation of EGRIFTA(TM) (tesamorelin for injection)
Marketwired - Mon Mar 30, 3:28PM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Health Canada has approved a Supplement to a New Drug Submission for the 1mg/vial presentation of EGRIFTA(TM) (tesamorelin for injection) (EGRIFTA(TM)).
TH.TO: 1.84 (+0.15)
IIROC Trade Halt - Theratechnologies Inc.
Newsfile Corp - Mon Mar 30, 2:59PM CDT
The following issues have been halted by IIROC:
Theratechnologies Announces Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations
Marketwired - Tue Feb 03, 6:16AM CST
Theratechnologies Inc. (TSX: TH) today announced that it has filed a Form 15 with the Securities and Exchange Commission ("SEC"
TH.TO: 1.84 (+0.15)